Latest news
Barinthus Biotherapeutics plc Revenue Breakdown – NASDAQ:BRNS - TradingViewTradingView · Sun, 09 Aug 2026 18:49:46 GMTDTI business registrations jump 9% on wholesale, retail surge - Manila BulletinManila Bulletin · Sun, 09 Aug 2026 16:02:36 GMTBarinthus Biotherapeut reports Q2 2026 net loss $10.6M, cash $59.6M; VTP-1000 MAD data due Q4 2026 - TradingViewTradingView · Thu, 06 Aug 2026 12:53:02 GMTBarinthus Biotherapeutics plc. 2026: Revenue ($9.78M), Net income ($10.58M), EPS ($0.26) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:51:01 GMTBRNS: Net loss narrowed on lower expenses; merger with Clywedog pending; cash runway extends 12+ months - TradingViewTradingView · Thu, 06 Aug 2026 12:48:34 GMTBarinthus Biotherapeutics PLC (BRNS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMT